New Pharma Search Engine Marketing Landscape

Manhattan ResearchPharmaceutical and healthcare market research company Manhattan Research releases its latest consumer marketing research module, "Pharmaceutical Search Engine Marketing: Leveraging Online Health Searching to Fulfill Brand Goals", as part of its ePharma Consumer® market research and strategic advisory service.

The Pharmaceutical Search Engine Marketing Module overviews the evolution of consumer search engine usage for health and pharmaceutical information in the new media landscape, how eHealth searching behavior varies along the treatment continuum, and best practices for integrating search in overall brand strategies, especially in light of new FDA regulations. The report also looks at emerging trends and technologies like mobile search, personalization, and real-time search, as well as the developments of Microsoft and its new engine Bing, especially in light of the company's recently announced partnership with Yahoo.

According to the report, successful pharmaceutical search campaigns can play an important role in leading valuable target customers from the research stage to becoming product users. Consumers who visit product sites are nearly three times more likely than the average U.S. adult to request prescriptions by name from their doctors. Increasing search engine visibility can help brands to reach consumers actively seeking health information and to effectively insert themselves into the patient-physician treatment discussions.

"Mastering search engine marketing is critical for brands looking to take advantage of consumers' increasing reliance on the Internet to figure out and manage their health issues," said Monique Levy, author of the report and Senior Director of Research at Manhattan Research. "The trouble is, mastering search is not as straightforward as it seems, especially with murky FDA guidelines and increasingly complex digital assets such as mobile and video."

Analysis Outline
Title: Pharmaceutical Search Engine Marketing: Leveraging Online Health Searching to Fulfill Brand Goals

Introduction

I. Search: An Overview

  • Types of Search
  • Up & Coming Search Topics

II. The Health & Pharma Search Market Landscape

  • eHealth Consumer Searcher Demographics
  • Comparing the Engines Used by eHealth Consumer Searchers

III. ePharma Search Engine Behavior

  • Understanding the Terms Consumers Use for Pharma Info
  • Decisions
  • Understanding How Consumers Select a Search Result
  • Ads
  • Credibility

III. Search Marketing Strategies for Health and Pharma Brands

  • Pharma Search Marketing within New FDA Regulations
  • Integrating Search in a Multichannel Strategy
  • Using Search Marketing to Facilitate the Path to Brand Goals
  • On-site Search
  • Measurement
  • Searching for Your Most Valuable Consumers
  • Key Learnings and Action Items

For an excerpt from the module and more information about its contents, please visit: http://www.manhattanresearch.com/products/Research_Modules/Consumer/pharma-health-search-engine-marketing.aspx.

Access to the "Pharmaceutical Search Engine Marketing" research module is immediately available to subscribers of Manhattan Research's ePharma Consumer® market research and strategic advisory service. For more information about becoming a subscriber to this service and gaining access to the in-depth consumer market data and analysis, visit http://www.manhattanresearch.com/products/Strategic_Advisory/ePC/.

About ePharma Consumer® v8.0
ePharma Consumer® v8.0 is Manhattan Research's consumer market research and strategic advisory service focused on consumers online for pharmaceutical information. In addition to the use of search engines for health and pharma information, ePharma Consumer® covers the impact of social networking/Web 2.0 and tracks consumer interaction with more than 250 branded and unbranded pharmaceutical sites, including in-depth data on the effect of DTC advertising, visitation, site search rationales, desired site tools and features, and actions taken off-site.

ePharma Consumer® v8.0 was conducted via online survey in Q4 2008 among 6,566 adults (age 18+). Overall market research can be segmented for over 85 condition groups. For additional product and subscription information, please visit http://www.manhattanresearch.com/products/Strategic_Advisory/ePC/.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.decisionresourcesinc.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...